NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
17,021,582
Share change
-1,493,845
Total reported value
$8,661,824
Price per share
$0.51
Number of holders
44
Value change
-$880,458
Number of buys
14
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q4 2022

As of 31 Dec 2022, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,021,582 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Lynx1 Capital Management LP, Redmile Group, LLC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, and BARCLAYS PLC. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.